Clinical Trial: A Phase 1 Clinical Study in Healthy Participants

U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07584876) titled 'A Phase 1 Clinical Study in Healthy Participants' on April 26.

Brief Summary: A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered BW-41012 in Healthy Participants

Study Start Date: May 15

Study Type: INTERVENTIONAL

Condition: HV

Intervention: DRUG: BW-40202 injection or Placebo

BW-40202 injection or Placebo dosage form is solution for injection and route of administration is subcutaneous injection

DRUG: BW-40202 injection or Placebo

BW-40202 injection or Placebo dosage form is solution ...